Parametric Portfolio Associates’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $1.45M | Buy |
48,564
+31,546
| +185% | +$943K | ﹤0.01% | 2591 |
|
|
2021
Q4 | $451K | Sell |
17,018
-5,592
| -25% | -$148K | ﹤0.01% | 3112 |
|
|
2021
Q3 | $821K | Sell |
22,610
-1,318
| -6% | -$47.9K | ﹤0.01% | 2887 |
|
|
2021
Q2 | $1.04M | Buy |
23,928
+1,188
| +5% | +$51.5K | ﹤0.01% | 2747 |
|
|
2021
Q1 | $778K | Buy |
22,740
+11,658
| +105% | +$399K | ﹤0.01% | 3277 |
|
|
2020
Q4 | $388K | Buy |
11,082
+496
| +5% | +$17.4K | ﹤0.01% | 3488 |
|
|
2020
Q3 | $254K | Sell |
10,586
-1,031
| -9% | -$24.7K | ﹤0.01% | 3557 |
|
|
2020
Q2 | $213K | Buy |
11,617
+2,830
| +32% | +$51.9K | ﹤0.01% | 3610 |
|
|
2020
Q1 | $137K | Sell |
8,787
-12,646
| -59% | -$197K | ﹤0.01% | 3657 |
|
|
2019
Q4 | $459K | Buy |
21,433
+3,974
| +23% | +$85.1K | ﹤0.01% | 3400 |
|
|
2019
Q3 | $326K | Buy |
17,459
+934
| +6% | +$17.4K | ﹤0.01% | 3498 |
|
|
2019
Q2 | $431K | Buy |
16,525
+14,851
| +887% | +$387K | ﹤0.01% | 3420 |
|
|
2019
Q1 | $43K | Sell |
1,674
-689
| -29% | -$17.7K | ﹤0.01% | 3892 |
|
|
2018
Q4 | $54K | Sell |
2,363
-4,032
| -63% | -$92.1K | ﹤0.01% | 3845 |
|
|
2018
Q3 | $205K | Sell |
6,395
-650
| -9% | -$20.8K | ﹤0.01% | 3752 |
|
|
2018
Q2 | $199K | Buy |
7,045
+4,058
| +136% | +$115K | ﹤0.01% | 3700 |
|
|
2018
Q1 | $106K | Buy |
2,987
+743
| +33% | +$26.4K | ﹤0.01% | 3850 |
|
|
2017
Q4 | $87K | Sell |
2,244
-251
| -10% | -$9.73K | ﹤0.01% | 3841 |
|
|
2017
Q3 | $63K | Sell |
2,495
-478
| -16% | -$12.1K | ﹤0.01% | 3980 |
|
|
2017
Q2 | $81K | Sell |
2,973
-109
| -4% | -$2.97K | ﹤0.01% | 3937 |
|
|
2017
Q1 | $102K | Buy |
3,082
+312
| +11% | +$10.3K | ﹤0.01% | 3689 |
|
|
2016
Q4 | $66K | Sell |
2,770
-6,376
| -70% | -$152K | ﹤0.01% | 3727 |
|
|
2016
Q3 | $336K | Sell |
9,146
-3,761
| -29% | -$138K | ﹤0.01% | 3364 |
|
|
2016
Q2 | $288K | Buy |
12,907
+330
| +3% | +$7.36K | ﹤0.01% | 3464 |
|
|
2016
Q1 | $262K | Sell |
12,577
-373
| -3% | -$7.77K | ﹤0.01% | 3650 |
|
|
2015
Q4 | $392K | Buy |
12,950
+489
| +4% | +$14.8K | ﹤0.01% | 3409 |
|
|
2015
Q3 | $308K | Buy |
12,461
+4,088
| +49% | +$101K | ﹤0.01% | 2948 |
|
|
2015
Q2 | $269K | Buy |
8,373
+1,009
| +14% | +$32.4K | ﹤0.01% | 3634 |
|
|
2015
Q1 | $263K | Buy |
7,364
+308
| +4% | +$11K | ﹤0.01% | 3623 |
|
|
2014
Q4 | $160K | Buy |
7,056
+2,584
| +58% | +$58.6K | ﹤0.01% | 3837 |
|
|
2014
Q3 | $87K | Sell |
4,472
-2,705
| -38% | -$52.6K | ﹤0.01% | 3736 |
|
|
2014
Q2 | $261K | Sell |
7,177
-1,458
| -17% | -$53K | ﹤0.01% | 3602 |
|
|
2014
Q1 | $335K | Buy |
8,635
+887
| +11% | +$34.4K | ﹤0.01% | 3384 |
|
|
2013
Q4 | $221K | Buy |
7,748
+3,780
| +95% | +$108K | ﹤0.01% | 3572 |
|
|
2013
Q3 | $142K | Buy |
+3,968
| New | +$142K | ﹤0.01% | 3677 |
|